YPSN:SWX
Ypsomed Holding AG
CHFÂ 356.80
arrow_upward
+0.79%(+2.80) 1D
Sep 14, 3:54:07 PM GMT+2 · CHF
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for YPSN...
Open
CHFÂ 350.00
High
CHFÂ 360.00
Low
CHFÂ 348.40
Mkt. cap
4.69B
Avg. vol.
14.27K
Volume
7.26K
Dividend
1.23%
Quarterly dividend
CHFÂ 1.10
Ex-dividend date
Jul 3, 2026
P/E ratio
21.88
52-wk high
CHFÂ 419.50
52-wk low
CHFÂ 260.50
EPS
CHFÂ 16.31
Shares outstanding
13.15M
No. of employees
2K
Open
CHFÂ 350.00
High
CHFÂ 360.00
Low
CHFÂ 348.40
Mkt. cap
4.69B
Avg. vol.
14.27K
Volume
7.26K
Dividend
1.23%
Quarterly dividend
CHFÂ 1.10
Ex-dividend date
Jul 3, 2026
P/E ratio
21.88
52-wk high
CHFÂ 419.50
52-wk low
CHFÂ 260.50
EPS
CHFÂ 16.31
Shares outstanding
13.15M
No. of employees
2K
Profile
Ypsomed Holding Inc. is a Swiss multinational medical technology company headquartered in Burgdorf, Switzerland. Founded in 2003, through the break up of Disetronic Group, founded by Willy Michel. Ypsomed specializes in developing and manufacturing injection and infusion systems for self-medication, primarily in the areas of diabetes care and biotechnology.
Products include devices like insulin pens, auto-injectors, and infusion pumps, which help patients manage chronic conditions more easily and independently. In 2025, Ypsomed employs 2,800+ employees and has an annual turnover of 728.9 million Swiss Francs. The company is listed on SIX Swiss Exchange. Wikipedia
About Ypsomed Holding AG